Table: Kyorin Pharmaceutical - 9-MTH group results

Kyorin Pharmaceutical

04/02/2026 05:00

Feb 4 (Reuters)- 
             Kyorin Pharmaceutical Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             92.46               89.29           127.00    
                 (+3.6 pct)          (+2.3 pct)       (-2.4 pct)  
  Operating          4.61                3.12             6.10    
                 (+47.9 pct)         (-35.1 pct)      (-51.5 pct) 
  Recurring          5.10                3.75             6.30    
                 (+35.8 pct)         (-30.4 pct)      (-52.3 pct) 
  Net                4.12                2.44             4.80    
                 (+68.9 pct)         (-41.2 pct)      (-47.2 pct) 
  EPS             71.71 yen           42.46 yen        83.55 yen  
  Ann Div                             57.00 yen        57.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             37.00 yen        37.00 yen  
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T